WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011156324) CGRP ANTIBODIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/156324    International Application No.:    PCT/US2011/039381
Publication Date: 15.12.2011 International Filing Date: 07.06.2011
IPC:
A61K 39/395 (2006.01)
Applicants: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center Indianapolis, Indiana 46285 (US) (For All Designated States Except US).
ALLAN, Barrett [US/US]; (US) (For US Only).
BENSCHOP, Robert Jan [NL/US]; (US) (For US Only).
CHAMBERS, Mark Geoffrey [GB/US]; (US) (For US Only).
DARLING, Ryan James [US/US]; (US) (For US Only)
Inventors: ALLAN, Barrett; (US).
BENSCHOP, Robert Jan; (US).
CHAMBERS, Mark Geoffrey; (US).
DARLING, Ryan James; (US)
Agent: MARTINEZ, Alejandro; Eli Lilly and Company P. O. Box 6288 Indianapolis, IN 46206-6288 (US)
Priority Data:
61/353,323 10.06.2010 US
Title (EN) CGRP ANTIBODIES
(FR) ANTICORPS ANTI-CGRP
Abstract: front page image
(EN)The present invention provides human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof for the treatment of osteoarthritis pain.
(FR)La présente invention concerne des anticorps humains génétiquement modifiés dirigés contre un peptide lié au gène de la calcitonine (GCRP) ou un fragment de liaison à l'antigène de ceux-ci. L'invention concerne également l'utilisation des anticorps humains génétiquement modifiés dirigés contre le peptide lié au gène de la calcitonine (GCRP) ou un fragment de liaison à l'antigène de ceux-ci pour le traitement de la douleur liée à l'arthrose.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)